Skip to content

Herb Cross

Chief Financial Officer at Jasper Therapeutics.

Earliest Form D on file: Aug 2026

Filed Aug 4, 2026

Jasper Therapeutics

Antibody drugs for chronic hives and rare immune diseases

Biotech, Redwood City CA

Signed as Chief Financial Officer

$132M

sold of $132M offered

Form D

LinkedIn

Network

At Jasper Therapeutics

9 people

3 more at Jasper Therapeutics